In the last trading session, 6.5 million Abbott Laboratories (NYSE:ABT) shares changed hands as the company’s beta touched 0.75. With the company’s per share price at $106.17 changed hands at $0.53 or 0.50% during last session, the market valuation stood at $184.70B. ABT’s last price was a discount, traded about -14.57% off its 52-week high of $121.64. The share price had its 52-week low at $89.67, which suggests the last value was 15.54% up since then. When we look at Abbott Laboratories’s average trading volume, we note the 3-month average coming to 5.59 million.
Abbott Laboratories (NYSE:ABT) trade information
Instantly ABT was in green as seen at the end of in last trading. With action 0.19%, the performance over the past five days has been green. The jump to weekly highs of 107.16 added 0.50% to the stock’s daily price. The company’s shares are showing year-to-date downside of -3.54%, with the 5-day performance at 0.19% in the green. However, in the 30-day time frame, Abbott Laboratories (NYSE:ABT) is -3.94% down.
Abbott Laboratories (ABT) estimates and forecasts
Data shows that the Abbott Laboratories share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 10.78% over the past 6 months, a 4.05% in annual growth rate that is considerably lower than the industry average of 17.70%. Year-over-year growth is forecast to reach 4.10% up from the last financial year.
Consensus estimates given by 17 financial analysts project the company’s revenue in the current quarter to hit an average of 10.37B. 17 analysts are of the opinion that Abbott Laboratories’s revenue for the current quarter will be 10.56B. The company’s revenue for the corresponding quarters a year ago was 9.7B. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 6.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 19.65%. The 2024 estimates are for Abbott Laboratories earnings to increase by 4.29%, but the outlook for the next 5-year period is at 8.10% per year.
ABT Dividends
Abbott Laboratories is expected to release its next quarterly earnings report in June. The 2.00% annual yield figure for the share gives it an annual dividend of 2.12. It is important to note, however, that the 2.00% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision.
